Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127017351 | 12701735 | 1 | I | 20160721 | 20160823 | 20160831 | 20160831 | EXP | GB-MHRA-EYC 00143945 | GB-DRREDDYS-GER/UKI/16/0082721 | DR REDDYS | 62.00 | YR | F | Y | 0.00000 | 20160831 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127017351 | 12701735 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | Oral | Y | U | UNKNOWN | 76255 | 2.5 | MG | ||||||
| 127017351 | 12701735 | 2 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 0 | 10 | MG | TID | |||||||||
| 127017351 | 12701735 | 3 | C | COCODAMOL | ACETAMINOPHENCODEINE PHOSPHATE | 1 | 0 | 2 | DF | TABLET | QID | ||||||||
| 127017351 | 12701735 | 4 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 54 | MG | 0 | 6 | MG | TABLET | QD | ||||||
| 127017351 | 12701735 | 5 | C | DIAZEPAM. | DIAZEPAM | 1 | 0 | ||||||||||||
| 127017351 | 12701735 | 6 | C | DIHYDROCODEINE | DIHYDROCODEINE | 1 | OCCASSIONALLY | 0 | 30 | MG | |||||||||
| 127017351 | 12701735 | 7 | C | FORTISIP | CARBOHYDRATESFATTY ACIDSMINERALSPROTEINVITAMINS | 1 | 0 | ||||||||||||
| 127017351 | 12701735 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | 20 | MG | TABLET | QD | ||||||||
| 127017351 | 12701735 | 9 | C | ORAMORPH | MORPHINE SULFATE | 1 | OCCASSIONAL | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127017351 | 12701735 | 1 | Delirium |
| 127017351 | 12701735 | 2 | Product used for unknown indication |
| 127017351 | 12701735 | 3 | Product used for unknown indication |
| 127017351 | 12701735 | 4 | Product used for unknown indication |
| 127017351 | 12701735 | 5 | Product used for unknown indication |
| 127017351 | 12701735 | 6 | Product used for unknown indication |
| 127017351 | 12701735 | 7 | Product used for unknown indication |
| 127017351 | 12701735 | 8 | Product used for unknown indication |
| 127017351 | 12701735 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127017351 | 12701735 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127017351 | 12701735 | Agitation | |
| 127017351 | 12701735 | Hypotension | |
| 127017351 | 12701735 | Musculoskeletal stiffness | |
| 127017351 | 12701735 | Neuroleptic malignant syndrome | |
| 127017351 | 12701735 | Pyrexia | |
| 127017351 | 12701735 | Somnolence | |
| 127017351 | 12701735 | Tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127017351 | 12701735 | 1 | 20160721 | 20160721 | 0 | |
| 127017351 | 12701735 | 4 | 20160712 | 0 |